Search

everythinglearnresearchcommunity

for

Search:↓

Male hormones, or androgens, affect women's health in areas like mood and bone density, and hormone replacement therapy using antiandrogenic progestogens can improve mood disorders and alertness in menopausal women.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

Menopause often leads to lower sexual desire and discomfort during sex, but treatment should be personalized and only if it bothers the woman.

Hormones like estrogen, testosterone, progesterone, and prolactin play complex roles in female sexual function, with testosterone potentially improving sexual desire, arousal, and satisfaction. However, more research is needed to establish safe and effective hormone treatments for female sexual dysfunction.

Testosterone treatment effectively causes male physical development in transgender male adolescents but may lead to side effects like acne, higher BMI and blood pressure, lower good cholesterol, and decreased bone density.

Cytokines and neuropeptides are key in controlling androgen levels, affecting skin and hair conditions.

The document concludes that Functional Hypothalamic Amenorrhea should be carefully diagnosed and managed to prevent health complications, using lifestyle changes and specific medications.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Testosterone therapy can modestly improve sexual function in menopausal women but should be used cautiously and is not recommended for routine measurement in sexual dysfunction or hirsutism.

Postmenopausal women with hyperandrogenism didn't have better metabolic health even after their testosterone levels became normal.

PCOS affects about 4% of women in the southeastern U.S. equally across Black and White populations.

Testosterone therapy can help improve sexual desire and function in postmenopausal women but may cause side effects and is not FDA-approved for this use.

PCOS affects a similar percentage of Black and White women in the Southeastern United States.

Estrogen loss during menopause worsens skin health, but hormone replacement therapy may improve it, though more research is needed.

Menopause significantly reduces skin collagen, leading to thinner, less elastic skin, and hormone replacement may help but requires careful consideration.

Estrogen helps prevent artery plaque by stopping monocyte capture in blood vessels.

Cyproterone acetate is effective for acne but less so for hirsutism and alopecia, with some side effects and quick menstrual cycle recovery after treatment.

Testosterone therapy and surgeries like mastectomy improve transgender men's lives and mental health with low risks and high satisfaction.

Finasteride may cause kidney damage.

Honey and bee pollen can help reduce menopausal symptoms in breast cancer patients.

Certain genetic variations in the AR and ERβ genes can affect androgen levels in women.

Short-term testosterone therapy in women seems safe with few mild side effects, but long-term effects need more research.

Benzodiazepines changed hormone levels but did not affect hair growth in women with idiopathic hirsutism.

Women with lichen planopilaris often have thyroid disease, depression, anxiety, and may respond to treatment with slowed disease progression.

The conclusion is that removing both ovaries is the best treatment for excess male hormones in postmenopausal women, with medication as another option, and managing insulin resistance is important for diagnosis and treatment.

Premature ovarian insufficiency (POI) can harm women's sexual health, and they may benefit from hormone therapy and counseling.

A woman developed male characteristics after using unregulated hormone therapy.

Hormonal imbalances during menopause may significantly contribute to Frontal Fibrosing Alopecia.

The 18-year-old girl likely has a condition called müllerian agenesis, which caused her to not have a uterus and experience no menstrual periods.

The meeting showcased rare skin disease cases, highlighting the need for accurate diagnosis and treatment.